Analysts' Actions: A Daily Roundup of Street Research

Exelexis estimates raised at Goldman: Goldman said it is increasing its estimates on EXEL for the full year to a loss of $1.22 a share from a loss of $1.44 a share. Maintained Inline rating.

Foxhollow estimates lowered at Morgan Stanley: Morgan Stanley said it is lowering its estimates on FOXH for the full year to a loss of 8 cents from a loss of 7 cents a share. Maintained Underweight rating.

Federal Signal estimates cut at Goldman: Goldman said it is lowering its estimates on FRP for the full year to 75-cents a share from 88-cents a share. Maintained Underperform rating.

Gen-Probe target raised at Piper: Piper said it is raising its target price on Piper to $62 due to improved West Nile Virus pricing. Maintained Outperform rating.

Home Depot estimates raised at Jefferies: Jefferies said it was raising FY 2006 EPS on HD by 4-cents to $3.12 on "blow out" Q4 results. Maintained Buy rating and $50 target.

Home Depot estimates raised at Morgan Stanley: Morgan Stanley said it is raising its estimates on HD for the full year 2007 to $3.08 a share from $2.98 a share. Maintained Equalweight rating.

Medtronic target lowered at Jefferies: Jefferies said it was raising FY 2006 EPS estimates on MDT by a penny to $2.21 but lowering the target by $2 to $59 on lackluster fiscal Q3 results. Maintained Hold rating.

Medtronic estimates lowered at UBS: UBS said it is lowering 2006 EPS estimates on MDT by a penny to $2.22 after F3Q results were inline. Maintained Buy rating.

Medtronic estimates lowered at Morgan Stanley: Morgan Stanley said it is lowering its estimates on MDT for the full year to $2.40 a share from $2.42 a share. Maintained Overweight rating.

Outback Steakhouse estimates lowered at Jefferies: Jefferies said it was lowering FY 2006 and 2007 EPS estimates on OSI from $2.49 and $2.73 to $1.68 and $2.17 respectively on analyst day following disappointing Q4 results. Maintained Hold rating and $49 target.